سوق علاج مرض فابري – المحركات والاتجاهات والفرص وإحصاءات النمو | 2031

  • Report Code : TIPRE00008240
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

مقدمة عن السوق

يعد مرض فابري واحدًا من مجموعة الحالات المعروفة باسم أمراض تخزين الليزوزومات. وهو مرض وراثي نادر يمكن أن يؤثر على أجزاء كثيرة من الجسم، بما في ذلك الكلى والقلب والجلد. يعاني المريض من نقص إنزيم ألفا جالاكتوزيداز الذي يؤدي إلى خلل وظيفي تدريجي في الأعضاء. يُطلق على التراكم غير الطبيعي لمادة دهنية معينة اسم globotriaosylceramide وهو المسؤول بشكل رئيسي عن تطور أمراض فابري.

ديناميكيات السوق

من المتوقع أن ينمو سوق علاج مرض فابري بسبب دعم الهيئات الحكومية لعلاج أمراض فابري مثل إدارة الغذاء والدواء (FDA). ومع ذلك، فإن الافتقار إلى الوعي بالتقدم في العلوم الوراثية والقيود التكنولوجية في منطقة معينة من العالم يعيق نمو السوق. علاوة على ذلك، فإن أنشطة البحث والتطوير المكثفة تقود سوق علاج مرض فابري في الفترة المتوقعة.

نطاق السوق

"سوق علاج مرض فابري" "التحليل حتى عام 2031" هو دراسة متخصصة ومتعمقة لصناعة الأدوية مع التركيز بشكل خاص على تحليل اتجاهات السوق العالمية. ويهدف التقرير إلى تقديم لمحة عامة عن سوق علاج مرض فابري مع تجزئة السوق التفصيلية حسب نوع الدواء والجغرافيا. من المتوقع أن يشهد سوق علاج مرض فابري نموًا مرتفعًا خلال الفترة المتوقعة. يقدم التقرير إحصائيات أساسية عن حالة السوق للاعبين الرائدين في سوق علاج أمراض فابري ويقدم الاتجاهات والفرص الرئيسية في السوق.

تقسيم السوق
< br /> يتم تقسيم سوق علاج مرض فابري على أساس نوع الدواء. استنادًا إلى نوع الدواء، يتم تقسيم السوق إلى العلاج ببدائل الإنزيم (ERT)، والعلاج المرافق، والعلاج بتخفيض الركيزة (SRT) وغيرها.


< br /> يقدم التقرير نظرة عامة مفصلة عن الصناعة بما في ذلك المعلومات النوعية والكمية. ويقدم لمحة عامة وتوقعات لسوق علاج الأمراض في فابري بناءً على مختلف القطاعات. كما يوفر حجم السوق والتقديرات المتوقعة من عام 2021 إلى 2031 فيما يتعلق بخمس مناطق رئيسية، وهي؛ أمريكا الشمالية وأوروبا وآسيا والمحيط الهادئ (APAC) والشرق الأوسط وأفريقيا (MEA) والجنوب والجنوب. أمريكا الوسطى. يتم تقسيم سوق علاج مرض فابري حسب كل منطقة لاحقًا حسب البلدان والقطاعات المعنية. يغطي التقرير التحليل والتوقعات لـ 18 دولة على مستوى العالم جنبًا إلى جنب مع الاتجاه الحالي والفرص السائدة في المنطقة.

يحلل التقرير العوامل التي تؤثر على سوق علاج مرض فابري من جانب الطلب والعرض ويقيم أيضًا ديناميكيات السوق المؤثرة. السوق خلال فترة التنبؤ، أي السائقين والقيود والفرص والاتجاه المستقبلي. ويقدم التقرير أيضًا تحليلاً شاملاً للآفات لجميع المناطق الخمس وهي؛ أمريكا الشمالية وأوروبا وآسيا والمحيط الهادئ والشرق الأوسط وأفريقيا والجنوب والأمبير. أمريكا الوسطى بعد تقييم العوامل السياسية والاقتصادية والاجتماعية والتكنولوجية التي تؤثر على سوق علاج مرض فابري في هذه المناطق.


اللاعبون في السوق

يغطي التقرير التطورات الرئيسية في سوق علاج أمراض فابري كاستراتيجيات نمو عضوية وغير عضوية. تركز العديد من الشركات على استراتيجيات النمو العضوي مثل إطلاق المنتجات والموافقات على المنتجات وغيرها مثل براءات الاختراع والأحداث. كانت استراتيجيات النمو غير العضوية التي شهدها السوق هي عمليات الاستحواذ والشراكة والشراكة. التعاون. وقد مهدت هذه الأنشطة الطريق لتوسيع الأعمال التجارية وقاعدة العملاء من اللاعبين في السوق. من المتوقع أن يكون لدى اللاعبين في السوق من سوق علاج مرض فابري فرص نمو مربحة في المستقبل مع الطلب المتزايد على سوق علاج مرض فابري في السوق العالمية. فيما يلي قائمة بعدد قليل من الشركات العاملة في سوق علاج مرض فابري.

يتضمن التقرير أيضًا ملفات تعريفية عن الشركات الرئيسية في سوق علاج مرض فابري إلى جانب تحليل SWOT واستراتيجيات السوق. بالإضافة إلى ذلك، يركز التقرير على اللاعبين الرائدين في الصناعة بمعلومات مثل ملفات تعريف الشركة والمكونات والخدمات المقدمة والمعلومات المالية لآخر 3 سنوات والتطورات الرئيسية في السنوات الخمس الماضية.

    •  Amicus Therapeutics Inc.• Avrobio Inc.• Grenovation Biotech GmbH• Idorsia Pharmaceuticals Ltd.• ISU Abxis Co Ltd.• JCR Pharmaceuticals Co Ltd• Moderna Therapeutics Inc.• Protalix Biotherapeutics Inc.• Sanofi SA• Shire Plc.
يتكون فريق البحث والتحليل المخصص لشركة Insight Partner من محترفين ذوي خبرة يتمتعون بخبرة إحصائية متقدمة ويقدمون خيارات تخصيص متنوعة في الدراسة الحالية.
  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Fabry Disease Treatment Market?

Fabry Disease Treatment Market is expected to grow at a CAGR of 6.8% between 2023-2031

What are the driving factors impacting the Fabry Disease Treatment Market?

Much of the treatment market for Fabry disease is propelled by several factors, including an ever-increasing incidence of the disease, new diagnostic techniques, and innovations in therapies. The enlarged demographic of senior citizens, coupled with awareness and earlier diagnosis, is fueling the growth of the market. Furthermore, both favorable reimbursement policies and increasing healthcare expenditure are working in favor of expensive treatments. In addition, a robust pipeline of therapeutic candidates under development is expected to propel the future growth of the market.

What are the future trends of the Fabry Disease Treatment Market?

Major changes are expected in the treatment market of Fabry disease in the years to come. Prominent factors influencing the treatment market are continued development of novel therapies, including gene therapy and small molecule inhibitors, which may offer more targeted and effective treatments. Advances in diagnostic techniques, particularly newborn screening, will mean earlier diagnosis and intervention. Additionally, the increasing focus on personalized medicine will drive the development of tailored treatment strategies based on individual patient characteristics. As the understanding of Fabry disease progresses and new therapies emerge, the market is poised for significant growth and transformation.

Which are the leading players operating in the Fabry Disease Treatment Market?

The leading players of the market are: Amicus Therapeutics Inc., Avrobio Inc., Greenovation Biotech GmbH, Idorsia Pharmaceuticals Ltd., ISU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd, Moderna Therapeutics Inc., Protalix Biotherapeutics Inc., Sanofi S.A., Shire Plc.

What are the deliverable formats of the Fabry Disease Treatment Market report?

The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

What are the options available for the customization of this report? 

Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Amicus Therapeutics Inc.
2. Avrobio Inc.
3. Greenovation Biotech GmbH
4. Idorsia Pharmaceuticals Ltd.
5. ISU Abxis Co Ltd.
6. JCR Pharmaceuticals Co Ltd
7. Moderna Therapeutics Inc.
8. Protalix Biotherapeutics Inc.
9. Sanofi S.A.
10. Shire Plc.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.